SERAFAST absorbable violet (5/0) DS-18 needle of 70 CM box of 24 sutures - Serag & Wiessner (JO103214) - Delynov

What is the SERAFAST absorbable violet (5/0) suture?

SERAFAST from the brand Serag-Wiessner is a synthetic, monofilament, and absorbable surgical suture material. This Class III medical device is designed from a segmented copolymer combining glycolide and e-caprolactone. Presented here in 5/0 calibre with a 70cm thread, it is distinguished by its monobloc structure which avoids the wicking effect and reduces the risk of plaque accumulation compared to braided threads. Its violet tint (D+C No. 2 dye) offers a clear visual contrast with surrounding tissues, facilitating the surgeon's precision work when placing sutures.

What are the clinical indications for this device?

In accordance with the specifications of the manufacturer Serag-Wiessner GmbH & Co. KG, this absorbable monofilament suture is indicated for soft tissue adaptation as well as for performing ligatures. Its use is particularly relevant in clinical situations where rapid resorption of the material is desired, typically for a period of up to two weeks. In oral surgery, it is used to stabilize wound edges after an extraction or a light periodontal intervention, where moderate tension and rapid healing are expected.

What are the technical characteristics of the DS-18 needle?

The DS-18 needle equipping this reference JO103214 is a high-quality surgical steel needle. The 'DS' code means it is a 3/8 circle needle equipped with a triangular reverse cutting tip. This specific geometry is ideal for passing through dense or fibrous tissues without causing unwanted tissue tearing, as the cutting edge is located on the convex curvature. The number 18 indicates a needle body length of 18 mm, offering an optimal compromise between maneuverability and control during the suturing of oral mucous membranes.

What are the contraindications for the use of SERAFAST?

The use of SERAFAST is formally contraindicated in cases where prolonged or permanent stability of the suture material is required by the surgical procedure. This includes in particular the fixation of synthetic implants such as heart valves. Furthermore, this device must not be used in interventions involving the central cardiovascular system or the central nervous system. Finally, its use is prohibited in patients with a known hypersensitivity or allergy to any of the components of this copolymer (glycolide and e-caprolactone) or to the violet dye.

How does resorption occur and what are the precautions?

Resorption of SERAFAST occurs by hydrolysis. This material is designed to provide effective tissue support over a short period, with the loss of tensile strength calibrated for rapid resorption within 2 weeks. It is recommended to use this thread with caution in patients with delayed healing, as the loss of thread strength could precede complete wound closure. As with any foreign body, particular attention must be paid to knotting techniques to ensure the security of the stitches, while taking into account the specific gliding characteristics of the monofilament.

Who is the manufacturer and what standards are met?

This medical device is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized company located in Germany. The product carries the CE1014 marking, certifying its compliance with European regulatory requirements for Class III medical devices. The suture material strictly complies with the European Pharmacopoeia (EP) monograph relating to sterile synthetic absorbable monofilament sutures. Each box contains 24 ready-to-use sutures, guaranteeing traceability and sterility in accordance with the most demanding hospital standards for oral surgery practice.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.